Bronchoprotective role for endogenous prostaglandin E2

214Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The possibility that impaired production of bronchoprotective factors contributes to the pathogenesis of asthma cannot be excluded. Prostaglandin E2 (PGE2) could be such a factor. It is a dominant cyclo-oxygenase product of airway epithelium and smooth muscle; it has inhibitory effects on inflammatory cells and pathways involved in bronchoconstriction at concentrations known to occur in the airway; inhalation of PGE2 has considerable bronchoprotective effects in patients with asthma; and manoeuvres that increase or decrease endogenous production of PGE2 have beneficial and deleterious effects on airway function. © 1995.

Cite

CITATION STYLE

APA

Pavord, I. D., & Tattersfield, A. E. (1995). Bronchoprotective role for endogenous prostaglandin E2. The Lancet, 345(8947), 436–438. https://doi.org/10.1016/S0140-6736(95)90409-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free